Pemphigus IgG Internalization and Desmosome Disassembly
天疱疮 IgG 内化和桥粒拆卸
基本信息
- 批准号:6805626
- 负责人:
- 金额:$ 15.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-09-30 至 2006-05-31
- 项目状态:已结题
- 来源:
- 关键词:antibody formationautoantibodybiological signal transductioncadherinscell adhesion moleculescell membraneclinical researchendocytosisenzyme linked immunosorbent assayfluorescence microscopyhuman tissueimmunoglobulin Gimmunoprecipitationintercellular connectionintermolecular interactionkeratinocytemolecular pathologypemphigusprotein bindingscintillation countertissue /cell culturewestern blottings
项目摘要
DESCRIPTION (provided by applicant):
Pemphigus vulgaris (PV) is a severe autoimmune blistering disease characterized by the disruption of adhesion between epithelial cells in the oral mucosa and in the lower layers of the epidermis. The antigen targeted by autoantibodies in this disease is the desmosomal cadherin desmoglein-3 (Dsg3). Desmosomes are cell-cell adhesion structures that play critical roles in the establishment and maintenance of epidermal integrity. A major consequence of Dsg3 autoantibody production is the disruption of desmosomal cell-cell adhesion, and it is likely that PV antibodies directly interfere with cell-cell adhesion mediated by Dsg3. However, numerous studies have also demonstrated that desmosomal components are internalized by keratinocytes exposed to PV sera, both in vivo and in vitro. In preliminary studies, we have found that PV sera as well as pathogenic monoclonal antibodies directed against Dsg3 are internalized by keratinocytes and enter the endocytic pathway. These observations raise the possibility that endocytosis of Dsg3 leads to a significant reduction of cell surface levels of Dsg3, and that Dsg3 internalization in response to PV antibodies may be causally related to pemphigus disease pathogenesis. Therefore, by inhibiting Dsg3 endocytosis in response to PV IgG ligation, it might be possible to blunt the impact ofPV autoantibodies on epithelial cellcell adhesion. In order to address this possibility, a sophisticated understanding of how membrane trafficking systems interface with desmosomal adhesion molecules is needed. This R21 proposal will test the hypothesis that pathogenic Dsg3 antibodies cause the internalization of this cell surface adhesion molecule. Two aims are proposed. First, we will establish as series of quantitative assays to monitor PV IgG internalization, and use these assays in combination with pharmacological and dominant negative approaches to determine the basic mechanisms by which Dsg3 is internalized. Secondly, we will determine if PV IgG and Dsg3 are internalized alone, or as a complex with other desmosomal molecules. We will then test the possibility that components of the desmosome regulate Dsg3 internalization. These experiments will form the foundation for a subsequent R01 application. The long-term goal of these studies is to expose new cellular pathways that might be targeted therapeutically to make keratinocytes more resistant to PV IgG in patients suffering from this devastating disease.
描述(由申请人提供):
寻常型天疱疮(PV)是一种严重的自身免疫性水疱病,其特征是口腔粘膜和表皮下层上皮细胞之间的黏附断裂。在这种疾病中,自身抗体靶向的抗原是桥粒钙粘蛋白桥粒桥粒蛋白-3(Dsg3)。桥粒是细胞间的黏附结构,在建立和维持表皮完整性方面起着关键作用。Dsg3自身抗体产生的一个主要后果是破坏桥粒细胞与细胞的黏附,可能是PV抗体直接干扰Dsg3介导的细胞与细胞的黏附。然而,大量的研究也表明,无论是在体内还是在体外,接触PV血清的角质形成细胞都能内化桥粒成分。在初步研究中,我们发现PV血清以及针对Dsg3的致病单抗被角质形成细胞内化并进入内吞途径。这些观察结果表明,Dsg3的内吞作用导致细胞表面Dsg3水平显著降低,并且Dsg3对PV抗体的内化可能与天疱疮的发病有关。因此,通过抑制Dsg3的内吞反应来回应PV的免疫球蛋白G,有可能减弱PV自身抗体对上皮细胞黏附的影响。为了解决这种可能性,需要对膜运输系统如何与桥粒黏附分子相互作用进行深入的了解。这项R21提案将检验致病Dsg3抗体导致这种细胞表面黏附分子内化的假设。提出了两个目标。首先,我们将建立一系列的定量检测方法来监测PV-Ig G内化,并结合药理学和显性阴性方法来确定Dsg3内化的基本机制。其次,我们将确定PV Ig G和Dsg3是单独内化,还是与其他桥粒分子形成复合体。然后我们将测试桥粒的组成部分调节Dsg3内化的可能性。这些实验将为后续的R01应用奠定基础。这些研究的长期目标是揭示新的细胞通路,这些通路可能是治疗上的靶向,以使角质形成细胞对这种毁灭性疾病患者的PV IgG具有更强的抵抗力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANDREW P. KOWALCZYK其他文献
ANDREW P. KOWALCZYK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANDREW P. KOWALCZYK', 18)}}的其他基金
Keratinocyte adhesion and signaling in the skin blistering disease pemphigus vulgaris
皮肤起疱病寻常型天疱疮中的角质形成细胞粘附和信号传导
- 批准号:
10732360 - 财政年份:2023
- 资助金额:
$ 15.3万 - 项目类别:
Cadherin regulation in dermal endothelial cells
真皮内皮细胞中钙粘蛋白的调节
- 批准号:
8526381 - 财政年份:2004
- 资助金额:
$ 15.3万 - 项目类别:
Cadherin Regulation in Dermal Endothelial Cells
真皮内皮细胞中钙粘蛋白的调节
- 批准号:
9381479 - 财政年份:2004
- 资助金额:
$ 15.3万 - 项目类别:
Cadherin Regulation in Dermal Endothelial Cells
真皮内皮细胞中钙粘蛋白的调节
- 批准号:
7227094 - 财政年份:2004
- 资助金额:
$ 15.3万 - 项目类别:
Cadherin Regulation in Dermal Endothelial Cells
真皮内皮细胞中钙粘蛋白的调节
- 批准号:
6929228 - 财政年份:2004
- 资助金额:
$ 15.3万 - 项目类别:
Cadherin Regulation in Dermal Endothelial Cells
真皮内皮细胞中钙粘蛋白的调节
- 批准号:
6820500 - 财政年份:2004
- 资助金额:
$ 15.3万 - 项目类别:
Cadherin Regulation in Dermal Endothelial Cells
真皮内皮细胞中钙粘蛋白的调节
- 批准号:
9982790 - 财政年份:2004
- 资助金额:
$ 15.3万 - 项目类别:
Cadherin Regulation in Dermal Endothelial Cells
真皮内皮细胞中钙粘蛋白的调节
- 批准号:
9752474 - 财政年份:2004
- 资助金额:
$ 15.3万 - 项目类别:
Cadherin regulation in dermal endothelial cells
真皮内皮细胞中钙粘蛋白的调节
- 批准号:
7727763 - 财政年份:2004
- 资助金额:
$ 15.3万 - 项目类别:
Cadherin regulation in dermal endothelial cells
真皮内皮细胞中钙粘蛋白的调节
- 批准号:
8185601 - 财政年份:2004
- 资助金额:
$ 15.3万 - 项目类别:
相似国自然基金
自身免疫性T细胞的抗原决定簇在抗肾小球基底膜病发病中的启动机制
- 批准号:81170645
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
受体编辑在天然自身反应性B细胞发育耐受中的作用和机制研究
- 批准号:30901336
- 批准年份:2009
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
抗肾小球基底膜抗体的免疫学特性在疾病发生和发展中的作用
- 批准号:30700752
- 批准年份:2007
- 资助金额:17.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Immunomodulatory effects of desmoglein 3 chimeric autoantibody receptor T cells (DSG3-CAART) in mucosal pemphigus vulgaris
桥粒芯糖蛋白 3 嵌合自身抗体受体 T 细胞 (DSG3-CAART) 对粘膜寻常型天疱疮的免疫调节作用
- 批准号:
10679911 - 财政年份:2023
- 资助金额:
$ 15.3万 - 项目类别:
Elucidating the immunology of autoantibody formation and function in COVID-19
阐明 COVID-19 中自身抗体形成和功能的免疫学
- 批准号:
10639707 - 财政年份:2023
- 资助金额:
$ 15.3万 - 项目类别:
Analysis of abnormal post-translational modifications that promote autoantibody production using high-precision mass spectrometry
使用高精度质谱分析促进自身抗体产生的异常翻译后修饰
- 批准号:
23K07915 - 财政年份:2023
- 资助金额:
$ 15.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Clinical application based on the molecular mechanism of autoantibody production in autoimmunity
基于自身抗体产生的分子机制在自身免疫中的临床应用
- 批准号:
23K18361 - 财政年份:2023
- 资助金额:
$ 15.3万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Dynamic prediction of type 1 diabetes risk and autoantibody status by a joint model of longitudinal and multistate models
通过纵向和多状态模型的联合模型动态预测1型糖尿病风险和自身抗体状态
- 批准号:
10630731 - 财政年份:2023
- 资助金额:
$ 15.3万 - 项目类别:
Novel therapeutic strategies targeting autoantibody-producing RP105-negative B cells by t-SNE method
通过 t-SNE 方法针对产生自身抗体的 RP105 阴性 B 细胞的新治疗策略
- 批准号:
23K07910 - 财政年份:2023
- 资助金额:
$ 15.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Impact of Obesity and Leptin on the Development of Immune System Dysfunction and Hypertension in Females with Systemic Lupus Erythematous
肥胖和瘦素对女性系统性红斑狼疮免疫系统功能障碍和高血压的影响
- 批准号:
10714532 - 财政年份:2023
- 资助金额:
$ 15.3万 - 项目类别:
Extracellular vesicle and autoantibody production
细胞外囊泡和自身抗体的产生
- 批准号:
23K15265 - 财政年份:2023
- 资助金额:
$ 15.3万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of mechanism of autoantibody production in pemphigus in conjunction with information from single cell analysis
结合单细胞分析信息阐明天疱疮自身抗体产生的机制
- 批准号:
22K08416 - 财政年份:2022
- 资助金额:
$ 15.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Influence of HTLV-1 for autoantibody production system and Th subset
HTLV-1对自身抗体产生系统和Th亚群的影响
- 批准号:
22K08552 - 财政年份:2022
- 资助金额:
$ 15.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)